Evome Medical Technologies, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other
Evome Medical Technologies, Inc. had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other of CAD 9.11 million as of 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Notes
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther · last filed 2024-04-16
- 2023-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other 9.11M CAD.
- 2023-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other 9.28M CAD.
- 2023-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other 12.73M CAD.
- 2023-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other 15.70M CAD.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other |
|---|---|
| 2023-12-31 | 9.11M CAD 10-K · filed 2024-04-16 |
| 2023-09-30 | 9.28M CAD 10-Q · filed 2023-11-14 |
| 2023-06-30 | 12.73M CAD 10-Q · filed 2023-08-14 |
| 2023-03-31 | 15.70M CAD 10-Q · filed 2023-05-15 |
| 2022-12-31 | 15.51M CAD 10-K · filed 2024-04-16 |
| 2022-11-30 | 13.09M CAD 10-Q · filed 2023-01-17 |
| 2022-08-31 | 10.76M CAD 10-Q · filed 2022-10-17 |
| 2022-05-31 | 2.70M CAD 10-Q · filed 2022-07-15 |
| 2022-02-28 | 13.00M CAD 10-KT · filed 2023-04-03 |
| 2021-12-31 | 18.85M CAD 10-KT · filed 2023-04-03 |
| 2021-11-30 | 18.85M CAD 10-Q · filed 2022-01-14 |
| 2021-08-31 | 12.08M CAD 10-Q · filed 2021-10-15 |
| 2021-05-31 | 12.08M CAD 10-Q/A · filed 2021-08-02 |
| 2021-02-28 | 0.00 CAD 10-K · filed 2022-05-31 |